SEC Form 4 · accession 0001493152-16-007162
OncBioMune Pharmaceuticals, Inc · OBMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Albert Kucharchuk
Officer — CFO & President · Director
Period of report
Sep 2, 2015
Accepted (ET)
Feb 4, 2016 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001362703
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Sep 2, 2015 | A | 5,000,000 | — | A | 5,000,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Grant of common stock to the reporting person.